Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $275.04 million. The enterprise value is $75.12 million.

Market Cap	275.04M
Enterprise Value	75.12M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KYTX has 43.25 million shares outstanding. The number of shares has increased by 577.31% in one year.

Current Share Class	43.25M
Shares Outstanding	43.25M
Shares Change (YoY)	+577.31%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	2.26%
Owned by Institutions (%)	25.96%
Float	22.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.61
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.03.

Current Ratio	5.39
Quick Ratio	5.32
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,769.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-91.92%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.27%
50-Day Moving Average	5.71
200-Day Moving Average	3.58
Relative Strength Index (RSI)	47.88
Average Volume (20 Days)	998,699

Short Selling Information

The latest short interest is 1.58 million, so 3.65% of the outstanding shares have been sold short.

Short Interest	1.58M
Short Previous Month	1.45M
Short % of Shares Out	3.65%
Short % of Float	7.02%
Short Ratio (days to cover)	1.91

Income Statement

Revenue	n/a
Gross Profit	-135.93M
Operating Income	-171.63M
Pretax Income	-158.70M
Net Income	-158.70M
EBITDA	-170.44M
EBIT	-171.63M
Earnings Per Share (EPS)	-$3.67

Balance Sheet

The company has $211.68 million in cash and $5.92 million in debt, giving a net cash position of $205.76 million or $4.76 per share.

Cash & Cash Equivalents	211.68M
Total Debt	5.92M
Net Cash	205.76M
Net Cash Per Share	$4.76
Equity (Book Value)	184.38M
Book Value Per Share	4.26
Working Capital	174.54M

Cash Flow

In the last 12 months, operating cash flow was -$141.41 million and capital expenditures -$638,000, giving a free cash flow of -$142.05 million.

Operating Cash Flow	-141.41M
Capital Expenditures	-638,000
Free Cash Flow	-142.05M
FCF Per Share	-$3.28

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-577.31%
Shareholder Yield	-577.31%
Earnings Yield	-56.50%
FCF Yield	-50.57%

Analyst Forecast

The average price target for KYTX is $19.00, which is 198.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	198.74%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1